1:00pm (EST) Vivus (VVUS, $8.40, up $0.32) is back in the spotlight but this time it’s not for news concerning its diet drug, Qnexa.  We have mentioned the battle between Vivus and others to be the first company to get a diet pill approved but Vivus also has plans toRead more

More